Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial.

Hill MD, Goyal M, Menon BK, Nogueira RG, McTaggart RA, Demchuk AM, Poppe AY, Buck BH, Field TS, Dowlatshahi D, van Adel BA, Swartz RH, Shah RA, Sauvageau E, Zerna C, Ospel JM, Joshi M, Almekhlafi MA, Ryckborst KJ, Lowerison MW, Heard K, Garman D, Haussen D, Cutting SM, Coutts SB, Roy D, Rempel JL, Rohr AC, Iancu D, Sahlas DJ, Yu AYX, Devlin TG, Hanel RA, Puetz V, Silver FL, Campbell BCV, Chapot R, Teitelbaum J, Mandzia JL, Kleinig TJ, Turkel-Parrella D, Heck D, Kelly ME, Bharatha A, Bang OY, Jadhav A, Gupta R, Frei DF, Tarpley JW, McDougall CG, Holmin S, Rha JH, Puri AS, Camden MC, Thomalla G, Choe H, Phillips SJ, Schindler JL, Thornton J, Nagel S, Heo JH, Sohn SI, Psychogios MN, Budzik RF, Starkman S, Martin CO, Burns PA, Murphy S, Lopez GA, English J, Tymianski M, ESCAPE-NA1 Investigators

Open source

DOI: 10.1016/s0140-6736(20)30258-0
Published: 2020 Mar 14
Container: Lancet (London, England)
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s0140-6736-20-30258-0,
  title = {Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial.},
  author = {Hill MD and Goyal M and Menon BK and Nogueira RG and McTaggart RA and Demchuk AM and Poppe AY and Buck BH and Field TS and Dowlatshahi D and van Adel BA and Swartz RH and Shah RA and Sauvageau E and Zerna C and Ospel JM and Joshi M and Almekhlafi MA and Ryckborst KJ and Lowerison MW and Heard K and Garman D and Haussen D and Cutting SM and Coutts SB and Roy D and Rempel JL and Rohr AC and Iancu D and Sahlas DJ and Yu AYX and Devlin TG and Hanel RA and Puetz V and Silver FL and Campbell BCV and Chapot R and Teitelbaum J and Mandzia JL and Kleinig TJ and Turkel-Parrella D and Heck D and Kelly ME and Bharatha A and Bang OY and Jadhav A and Gupta R and Frei DF and Tarpley JW and McDougall CG and Holmin S and Rha JH and Puri AS and Camden MC and Thomalla G and Choe H and Phillips SJ and Schindler JL and Thornton J and Nagel S and Heo JH and Sohn SI and Psychogios MN and Budzik RF and Starkman S and Martin CO and Burns PA and Murphy S and Lopez GA and English J and Tymianski M and ESCAPE-NA1 Investigators},
  year = {2020},
  journal = {Lancet (London, England)},
  doi = {10.1016/s0140-6736(20)30258-0},
  url = {https://doi.org/10.1016/s0140-6736(20)30258-0}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial.
AU  - Hill MD
AU  - Goyal M
AU  - Menon BK
AU  - Nogueira RG
AU  - McTaggart RA
AU  - Demchuk AM
AU  - Poppe AY
AU  - Buck BH
AU  - Field TS
AU  - Dowlatshahi D
AU  - van Adel BA
AU  - Swartz RH
AU  - Shah RA
AU  - Sauvageau E
AU  - Zerna C
AU  - Ospel JM
AU  - Joshi M
AU  - Almekhlafi MA
AU  - Ryckborst KJ
AU  - Lowerison MW
AU  - Heard K
AU  - Garman D
AU  - Haussen D
AU  - Cutting SM
AU  - Coutts SB
AU  - Roy D
AU  - Rempel JL
AU  - Rohr AC
AU  - Iancu D
AU  - Sahlas DJ
AU  - Yu AYX
AU  - Devlin TG
AU  - Hanel RA
AU  - Puetz V
AU  - Silver FL
AU  - Campbell BCV
AU  - Chapot R
AU  - Teitelbaum J
AU  - Mandzia JL
AU  - Kleinig TJ
AU  - Turkel-Parrella D
AU  - Heck D
AU  - Kelly ME
AU  - Bharatha A
AU  - Bang OY
AU  - Jadhav A
AU  - Gupta R
AU  - Frei DF
AU  - Tarpley JW
AU  - McDougall CG
AU  - Holmin S
AU  - Rha JH
AU  - Puri AS
AU  - Camden MC
AU  - Thomalla G
AU  - Choe H
AU  - Phillips SJ
AU  - Schindler JL
AU  - Thornton J
AU  - Nagel S
AU  - Heo JH
AU  - Sohn SI
AU  - Psychogios MN
AU  - Budzik RF
AU  - Starkman S
AU  - Martin CO
AU  - Burns PA
AU  - Murphy S
AU  - Lopez GA
AU  - English J
AU  - Tymianski M
AU  - ESCAPE-NA1 Investigators
PY  - 2020
JO  - Lancet (London, England)
DO  - 10.1016/s0140-6736(20)30258-0
UR  - https://doi.org/10.1016/s0140-6736(20)30258-0
ER  -

APA

MD, H., M, G., BK, M., RG, N., RA, M., AM, D., AY, P., BH, B., TS, F., D, D., BA, V. A., RH, S., RA, S., E, S., C, Z., JM, O., M, J., MA, A., KJ, R., MW, L., K, H., D, G., D, H., SM, C., SB, C., D, R., JL, R., AC, R., D, I., DJ, S., AYX, Y., TG, D., RA, H., V, P., FL, S., BCV, C., R, C., J, T., JL, M., TJ, K., D, T., D, H., ME, K., A, B., OY, B., A, J., R, G., DF, F., JW, T., CG, M., S, H., JH, R., AS, P., MC, C., G, T., H, C., SJ, P., JL, S., J, T., S, N., JH, H., SI, S., MN, P., RF, B., S, S., CO, M., PA, B., S, M., GA, L., J, E., M, T., & Investigators, E. (2020). Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial.. Lancet (London, England). https://doi.org/10.1016/s0140-6736(20)30258-0

Source records

pubmed · retrieved 2026-09-25T15:19:28.143Z